Papers

1

Total Citations

17

H-Index

1

About

Yuetong Ji is a rising leader in clinical microbiology and antimicrobial resistance research, with a focus on developing rapid, automated diagnostic tools to combat multidrug-resistant pathogens. Her most cited work introduces CAST-R, a groundbreaking system for automated antimicrobial susceptibility testing (AST) directly from positive blood cultures, dramatically reducing turnaround time while improving reliability. Using tigecycline susceptibility in sepsis as a model, Ji’s approach addresses critical bottlenecks in traditional AST methods, which are often slow, labor-intensive, and prone to variability. This innovation has immediate implications for sepsis management, enabling faster, more targeted antibiotic therapy and helping curb the spread of resistance. With 17 citations on this flagship paper alone, Ji’s contributions are gaining traction among clinicians and researchers seeking practical solutions for real-world diagnostic challenges. Her work bridges automation, clinical microbiology, and patient care, positioning her as a key figure in the next generation of infectious disease diagnostics. For students and researchers, Ji’s research exemplifies how engineering-driven approaches can transform routine lab practices into powerful weapons against the global antimicrobial resistance crisis.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Rapid, automated, and reliable antimicrobial susceptibility test from positive blood culture by CAST‐R
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Qingdao Institute of Bioenergy and Bioprocess Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago